NCT07288047 Virtual Reality as a Method for Pain and Anxiety Control During First Trimester Procedural Abortion
| NCT ID | NCT07288047 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Study Investigator |
| Condition | Abortion, First Trimester |
| Study Type | INTERVENTIONAL |
| Enrollment | 72 participants |
| Start Date | 2026-05-01 |
| Primary Completion | 2026-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 72 participants in total. It began in 2026-05-01 with a primary completion date of 2026-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn whether use of a virtual reality (VR) headset showing a meditative nature video will help reduce pain and anxiety during a first trimester procedural abortion. Investigators will enroll 72 patients undergoing a first trimester procedural abortion with usual care to manage pain and anxiety compared to use of a VR headset in addition to usual care to see if use of the VR headset will decrease pain and anxiety and increase satisfaction with the procedure.
Eligibility Criteria
Inclusion Criteria: * Patients at Planned Parenthood of Western Pennsylvania who have decided to undergo and are eligible for a procedural abortion. * 18 years old or older * \<14 weeks gestation on day of abortion * Able to comprehend written English * Willing to comply with the study protocol * Willing and able to provide informed consent Exclusion Criteria: * History of vertigo * History of epilepsy * Claustrophobia * Significant hearing or visual impairments (such as deafness or blindness) * Require hearing aids * Have an implanted medical device, such as cardiac pacemaker or defibrillator * Require misoprostol for cervical preparation * Prior unsuccessful attempt at abortion during this pregnancy
Contact & Investigator
Study Coordinator
STUDY DIRECTOR
Univeristy of Pittsburgh
Frequently Asked Questions
Who can join the NCT07288047 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Abortion, First Trimester. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07288047 currently recruiting?
Yes, NCT07288047 is actively recruiting participants. Contact the research team at fpr@upmc.edu for enrollment information.
Where is the NCT07288047 trial being conducted?
This trial is being conducted at Pittsburgh, United States, Pittsburgh, United States.
Who is sponsoring the NCT07288047 clinical trial?
NCT07288047 is sponsored by Study Investigator. The principal investigator is Study Coordinator at Univeristy of Pittsburgh. The trial plans to enroll 72 participants.